Compounds > levonorgestrel
Page last updated: 2024-08-21

levonorgestrel and Purpura, Thrombotic Thrombocytopenic

levonorgestrel has been researched along with Purpura, Thrombotic Thrombocytopenic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Green, L; Wysowski, DK1
Fraser, JL; Kruskall, MS; Malynn, ER; Millenson, M; Uhl, L1

Other Studies

2 other study(ies) available for levonorgestrel and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Obstetrics and gynecology, 1995, Volume: 85, Issue:4

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Cerebrovascular Disorders; Combined Modality Therapy; Debridement; Drainage; Drug Implants; Female; Hospitalization; Humans; Levonorgestrel; Plasmapheresis; Pseudotumor Cerebri; Purpura, Thrombotic Thrombocytopenic; Surgical Wound Infection; United States; United States Food and Drug Administration

1995
Possible association between the Norplant contraceptive system and thrombotic thrombocytopenic purpura.
    Obstetrics and gynecology, 1996, Volume: 87, Issue:5 Pt 2

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Contraceptive Agents, Female; Female; Humans; Incidence; Levonorgestrel; Purpura, Thrombotic Thrombocytopenic; United States; United States Food and Drug Administration

1996